A meta-analysis has shown that PVT1 has moderate value in discriminating HCC from control with a summary receiver operating characteristic of 0.81 (95%CI: 0.77–0.84), thus suggesting the potential of PVT1 as a diagnostic indicator for liver cancer (89). This evidence concerns the gene PVT1 and hepatocellular carcinoma.